Skip to main navigation Skip to search Skip to main content

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

  • Asim Amin
  • , David H. Lawson
  • , April K.S. Salama
  • , Henry B. Koon
  • , Troy Guthrie
  • , Sajeve S. Thomas
  • , Steven J. O'Day
  • , Montaser F. Shaheen
  • , Bin Zhang
  • , Stephen Francis
  • , F. Stephen Hodi

Research output: Contribution to journal › Article › peer-review

57   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science